tiprankstipranks
Trending News
More News >
Indaptus Therapeutics (INDP)
NASDAQ:INDP
US Market

Indaptus Therapeutics (INDP) Income Statement

Compare
559 Followers

Indaptus Therapeutics Income Statement

Last quarter (Q3 2025), Indaptus Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Indaptus Therapeutics's net income was $-2.98M. See Indaptus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 15.37M$ 16.38M$ 14.91M$ 7.73M$ 3.60M
Depreciation and Amortization
$ 735.00$ 1.28K$ 1.78K$ 1.40K$ 852.00
EBITDA
$ -15.37M$ -16.38M$ -14.91M$ -7.73M$ -3.60M
Operating Income
$ -15.37M$ -16.38M$ -14.91M$ -7.73M$ -3.60M
Other Income/Expenses
$ 343.72K$ 955.00K$ 588.11K$ 17.72K$ 15.11K
Pretax Income
$ -15.02M$ -15.42M$ -14.32M$ -7.71M$ -3.58M
Net Income
$ -15.02M$ -15.42M$ -14.32M$ -7.71M$ -3.58M
Per Share Metrics
Basic EPS
$ -1.61$ -1.84$ -1.73$ -1.89$ -0.66
Diluted EPS
$ -1.61$ -1.84$ -1.73$ -1.89$ -0.66
Weighted Average Shares Outstanding
9.36M 8.40M 8.26M 4.09M 5.41M
Weighted Average Shares Outstanding (Diluted)
9.36M 8.40M 8.26M 4.09M 5.41M
Currency in USD

Indaptus Therapeutics Earnings and Revenue History